The role of peritumoral CD8 + /TIA1 + lymphocytes in hepatocellular carcinoma aggressiveness and recurrence after surgical resection.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 24 05 2022
revised: 08 07 2022
accepted: 09 07 2022
pubmed: 26 7 2022
medline: 26 10 2022
entrez: 25 7 2022
Statut: ppublish

Résumé

Hepatocellular carcinoma (HCC) is characterized by a low mutation burden and a relatively low number of tumor-infiltrating lymphocytes (TILs), making still difficult to identify targets for specific therapies. The aim of this study was the identification of the prognostic role of TILs in HCC, focusing on their distribution and status of activation. We retrospectively enrolled 41 patients, undergone to liver resection for HCC. A significant increase of CD8 + intratumoral lymphocytes was observed in HCCs with prevalent solid architecture, but with a higher PD-1/TIA1 ratio, suggesting that HCCs with solid architecture have more peri-tumoral lymphocytes, but with minor functionality. At multivariate and univariate analyses, TIA1/CD8 ratio correlated with tumor recurrence, meaning that HCC with more activated TILs are characterized by a higher tumor aggressiveness. The use of a feasible and cheap immunohistochemical panel can help in post-surgical prognostic stratification, focusing not only in the raw number and density of TILs, but more on their state of activation and morphology.

Identifiants

pubmed: 35872367
pii: S0344-0338(22)00260-6
doi: 10.1016/j.prp.2022.154016
pii:
doi:

Substances chimiques

Programmed Cell Death 1 Receptor 0
TIA1 protein, human 0
T-Cell Intracellular Antigen-1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154016

Informations de copyright

Copyright © 2022 Elsevier GmbH. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest This research received no external funding. The authors declare no conflict of interest.

Auteurs

Clara Bertuzzi (C)

Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Giuliana Germinario (G)

Transplant and General Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Simona Righi (S)

Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Matteo Ravaioli (M)

Transplant and General Surgery Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Claudio Agostinelli (C)

Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Andrea Pession (A)

Pediatric Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Antonia D'Errico (A)

Pathology Unit, IRCCS S.Orsola-Malpighi University Hospital, Bologna, Italy.

Elena Sabattini (E)

Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

Francesco Vasuri (F)

Pathology Unit, IRCCS S.Orsola-Malpighi University Hospital, Bologna, Italy. Electronic address: francesco.vasuri@aosp.bo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH